Missed out on Moderna’s incredible 2,365% surge?
Don’t worry, this was just the beginning…
Something MUCH bigger is around the corner.
You see, you could’ve turned every $2,500 into $61,625 with Moderna when they pumped out close to one BILLION Covid-19 vaccine doses in record time…
But Moderna could’ve never done it alone.
Because drugs based on mRNA have never been mass-manufactured before…
And Moderna had to turn to a little-known Boston-based company for help.
Ramping up production like this wouldn’t have been possible without this company’s proprietary method.
It has been in the making for more than a decade…
Now it brilliantly passed its trial by fire during the Covid-19 crisis.
And Moderna isn’t this company’s only customer…
For example, it helps Roche develop next-gen antibiotics…
And cannabis manufacturer Cronos Group to increase cannabinoid output by as much as 50X!
Yet, this company is flying almost completely under the radar.
Insiders understand this could be the century’s most valuable innovation.
That’s why some of the best-connected investors like Bill Gates or ARK’s Cathie Woods poured almost $1 billion into this firm while it was still private.
It just went public and today you have the chance to get in on the ground floor… shares still trade for less than $15.
However, this window of opportunity is closing fast…
This firm’s CEO has recently been on CNBC… CBS… and Bloomberg.
And the investment public could wake up to this once-in-a-lifetime opportunity any moment now.
Find out what this is all about while there’s still time to get in early…
Sincerely,
Jeff Siegel
Investment Director, Green Chip Stocks
